Tag: Intellia’s success in CRISPR therapy
CRISPR Therapy Shows Superior Benefit for Cardiomyopathy Patients
Intellia Therapeutics CEO John Leonard has been facing a familiar situation for the past few years. The company has been sharing positive results from its gene editing trials, only to see its stock prices...